Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bio-Path Holdings Inc (NASDAQ: BPTH)

 
BPTH Technical Analysis
5
As on 9th Jun 2023 BPTH STOCK Price closed @ 1.58 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.47 & Strong Sell for SHORT-TERM with Stoploss of 3.77 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BPTHSTOCK Price

Open 1.66 Change Price %
High 1.67 1 Day -0.07 -4.24
Low 1.58 1 Week -0.07 -4.24
Close 1.58 1 Month 0.29 22.48
Volume 12700 1 Year -2.74 -63.43
52 Week High 4.43 | 52 Week Low 1.22
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
BPTH
Daily Charts		 BPTH
Intraday Charts		 Whats New @
Bazaartrend		 BPTH
Free Analysis
 
BPTH Important Levels Intraday
RESISTANCE1.75
RESISTANCE1.70
RESISTANCE1.66
RESISTANCE1.63
SUPPORT1.53
SUPPORT1.50
SUPPORT1.46
SUPPORT1.41
 
BPTH Forecast May 2024
Share
4th UP Forecast3.3
3rd UP Forecast2.75
2nd UP Forecast2.41
1st UP Forecast2.07
1st DOWN Forecast1.09
2nd DOWN Forecast0.75
3rd DOWN Forecast0.41
4th DOWN Forecast-0.14
 
BPTH Weekly Forecast
4th UP Forecast2.95
3rd UP Forecast2.51
2nd UP Forecast2.24
1st UP Forecast1.97
1st DOWN Forecast1.19
2nd DOWN Forecast0.92
3rd DOWN Forecast0.65
4th DOWN Forecast0.21
 
BPTH Forecast2024
4th UP Forecast7.94
3rd UP Forecast5.9
2nd UP Forecast4.64
1st UP Forecast3.38
1st DOWN Forecast-0.22
2nd DOWN Forecast-1.48
3rd DOWN Forecast-2.74
4th DOWN Forecast-4.78
 
 
BPTH Other Details
Segment EQ
Market Capital 33266782.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BPTH Address
BPTH
 
BPTH Latest News
 
Your Comments and Response on Bio-Path Holdings Inc
 
BPTH Business Profile
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. The company is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas. Address: 4710 Bellaire Boulevard, Bellaire, TX, United States, 77401
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service